The oncology market is expected to experience significant growth, with projected values ranging from $668.26 billion to $732.45 billion by the mid-2030s. The US oncology market is also anticipated to surge, driven by a rising cancer burden. The growth of the oncology market is linked to advances in precision medicine, which is itself expected to expand rapidly, with a projected market size of up to $470.53 billion by 2034.